ALBUQUERQUE, N.M. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) (www.biomoda.com) has allied with Quintiles Global Central Laboratories (www.quintiles.com) to help refine the automated image recognition system for measuring the photon emission rate and cell morphology of CyPath®-stained cells to detect early stage lung cancer.
